{"id":25527,"date":"2025-05-14T06:13:52","date_gmt":"2025-05-14T05:13:52","guid":{"rendered":"https:\/\/k2info.w.uib.no\/?p=25527"},"modified":"2025-05-14T06:13:52","modified_gmt":"2025-05-14T05:13:52","slug":"disputas-luka-tandaric-23-05-25","status":"publish","type":"post","link":"https:\/\/k2info.w.uib.no\/nb_no\/2025\/05\/14\/disputas-luka-tandaric-23-05-25\/","title":{"rendered":"[:no]Disputas | Luka Tandaric | 23.05.25[:en]Defence | Luka Tandaric | 23.05.25[:]"},"content":{"rendered":"

[:no]<\/p>\n

\"\"<\/a>DET MEDISINSKE FAKULTET<\/strong><\/h2>\n

UNIVERSITETET I BERGEN<\/strong>\u00a0<\/strong><\/h2>\n

DISPUTAS \u2013 PH.D.-GRADEN\u00a0<\/strong><\/h1>\n

Luka Tandaric<\/strong><\/h2>\n

Kandidaten utg\u00e5r fra Klinisk institutt 2<\/em><\/p>\n

Hovedveileder: professor Line Bj\u00f8rge
\nMedveiledere: professor Emmet McCormack, ph.d. Liv Cecilie Vestrheim Thomsen og forsker Katrin Kleinmanns<\/em><\/p>\n

Pr\u00f8veforelesning: Fredag 23. mai 2025 kl. 10.15<\/strong><\/h3>\n

Sted: Auditorium, Armauer Hansens Hus, Haukelandsveien 28<\/p>\n

Oppgitt emne: \u00abTargeted therapies in cancer – from their introduction to future perspectives\u00bb<\/p>\n

Dispuptas: Fredag 23. mai 2025 kl. 12.15<\/strong><\/h3>\n

Sted: Auditorium, Armauer Hansens Hus, Haukelandsveien 28<\/p>\n

Avhandlingens tittel: \u201cRethinking High-Grade Serous Ovarian Carcinoma: Towards Personalized Immunotherapy through Preclinical, Translational and Clinical Evaluation of Combined CD73 and PD-L1 Blockade\u201d<\/p>\n

    \n
  1. opponent: Professor Frederic Amant, Katholieke Universiteit Leuven, Belgia<\/li>\n
  2. opponent: Professor Leticia Oliveira-Ferrer, Universit\u00e4tsklinikum Hamburg-Eppendorf, Tyskland<\/li>\n
  3. medlem av komiteen: Forsker Carina Strell, Universitetet i Bergen<\/li>\n<\/ol>\n

    Disputasen blir ledet av professor emerita Birgitta \u00c5sj\u00f8.<\/p>\n

    \u00c5pent for alle interesserte<\/p>\n

    [:en]\"\"<\/a><\/p>\n

    FACULTY OF MEDICINE<\/strong>
    \nUNIVERSITY OF BERGEN<\/strong><\/h2>\n

    DEFENSE \u2013 PH.D. DEGREE<\/strong><\/h1>\n

    Luka Tandaric<\/strong><\/h2>\n

    The candidate is affiliated with the Department of Clinical Science (Klinisk institutt 2)
    \nMain supervisor<\/strong>: Professor Line Bj\u00f8rge
    \nCo-supervisors<\/strong>: Professor Emmet McCormack, Ph.D. Liv Cecilie Vestrheim Thomsen, and Researcher Katrin Kleinmanns<\/p>\n

    Trial lecture<\/strong>:Friday, May 23, 2025, at 10:15 AM<\/strong><\/h3>\n


    \n<\/strong>Location<\/strong>: Auditorium, Armauer Hansen\u2019s House, Haukelandsveien 28
    \nAssigned topic<\/strong>:\u00a0«Targeted therapies in cancer \u2013 from their introduction to future perspectives»<\/em><\/p>\n

    Public defense<\/strong>:Friday, May 23, 2025, at 12:15 PM<\/strong><\/h3>\n

    \nLocation<\/strong>: Auditorium, Armauer Hansen\u2019s House, Haukelandsveien 28<\/p>\n

    Title of the dissertation<\/strong>:
    \n«Rethinking High-Grade Serous Ovarian Carcinoma: Towards Personalized Immunotherapy through Preclinical, Translational and Clinical Evaluation of Combined CD73 and PD-L1 Blockade»<\/em><\/p>\n

    1st opponent<\/strong>: Professor Frederic Amant, Katholieke Universiteit Leuven, Belgium
    \n2nd opponent<\/strong>: Professor Leticia Oliveira-Ferrer, University Medical Center Hamburg-Eppendorf, Germany
    \n3rd member of the committee<\/strong>: Researcher Carina Strell, University of Bergen<\/p>\n

    The defense will be chaired by Professor Emerita Birgitta \u00c5sj\u00f8.<\/p>\n

    Open to all interested parties<\/strong><\/p>\n

    [:]<\/p>\n","protected":false},"excerpt":{"rendered":"

    [:no] DET MEDISINSKE FAKULTET UNIVERSITETET I BERGEN\u00a0 DISPUTAS \u2013 PH.D.-GRADEN\u00a0 Luka Tandaric Kandidaten utg\u00e5r fra Klinisk institutt 2 Hovedveileder: professor Line Bj\u00f8rge Medveiledere: professor Emmet McCormack, ph.d. Liv Cecilie Vestrheim Thomsen og forsker Katrin Kleinmanns Pr\u00f8veforelesning: Fredag 23. mai 2025…<\/p>\n

    Read more →<\/a><\/p>\n","protected":false},"author":5375,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[44],"tags":[],"class_list":["post-25527","post","type-post","status-publish","format-standard","hentry","category-nyheter"],"_links":{"self":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/25527","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/users\/5375"}],"replies":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/comments?post=25527"}],"version-history":[{"count":1,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/25527\/revisions"}],"predecessor-version":[{"id":25529,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/25527\/revisions\/25529"}],"wp:attachment":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/media?parent=25527"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/categories?post=25527"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/tags?post=25527"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}